AzTrials
AzTrials

Shoulder and Elbow InjuryAr-KJOCNCT07729306

TRANSLATION, ADAPTATION, VALIDATION AND RELIABILITY OF ARABIC VERSION OF KERLAN-JOBE ORTHOPAEDIC CLINIC SHOULDER AND ELBOW SCORE IN EGYPTIAN SYMPTOMATIC OVERHEAD ATHLETES

An observational study of Shoulder and Elbow Injury, run by Ziad Mohamed Mohamed Abdalla Haroun at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

PURPOSE: To perform a cross-cultural adaption of the KJOC Shoulder and Elbow score into the Arabic language, then to test its validity and reliability. BACKGROUND: Shoulder and elbow injuries are highly prevalent among overhead and throwing athletes, particularly in sports such as baseball, handball, volleyball, and… Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Shoulder and Elbow Injury
What is being tested?
Questionnaire and Physical Exam
How many people
100 participants
Where
1 siteEgypt
Study dates
1 Jun 2026to 1 Jul 2026
How long will I take part?
1 Week
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: This study will be conducted on 100 symptomatic Egyptian overhead athletes. They will be screened for inclusion and exclusion criteria.

Who may be able to join

  • Male or female symptomatic athletes who participates in overhead sports (badminton, water polo, basketball, baseball, softball, handball, volleyball, or tennis) at least twice a week (Paraskevopoulos et al., 2024).
  • Age ranges from 18 to 45 years old (Schulz et al., 2022).
  • Non illiterate native Arabic speakers

Who cannot join

  • History of upper limb injury or any other injury that prevents the athlete from actively participating in their sport (Sukanen et al., 2022).
  • History of recent upper limb trauma, neuropathic pain, or surgery (Sasagawa et al., 2024).
  • Asymptomatic athletes who participate in overhead sports
  • Occurrence of a new injury during the study's reliability assessment interval (Sedighimehr, 2020).
  • Surgery that prevents full sports participation
  • Arabic speakers who are not native speakers.
  • Being illiterate or unable to read Arabic.
  • Visual or cognitive difficulties that make it difficult to read the questionnaire or take part in the interview.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo

Other trials in Egypt

About this study

PURPOSE:

To perform a cross-cultural adaption of the KJOC Shoulder and Elbow score into the Arabic language, then to test its validity and reliability.

Read more

BACKGROUND:

Shoulder and elbow injuries are highly prevalent among overhead and throwing athletes, particularly in sports such as baseball, handball, volleyball, and tennis throwing. Accurate assessment of upper extremity function in this athletic population is essential for injury prevention, clinical decision-making, and monitoring return-to-sport outcomes.

The Kerlan-Jobe Orthopaedic Clinic (KJOC) Shoulder and Elbow Score is a sport-specific, patient-reported outcome measure (PROM) developed to evaluate functional performance, pain, and sport-related limitations in overhead athletes. It has been widely used and validated in several languages including Spanish, Germany, Japanese, and Greek; however, no validated Arabic version is currently available.

Simple literal translation is insufficient for patient-reported outcome measures. Instead, a structured process of translation, cultural adaptation, and comprehensive psychometric validation is required to ensure linguistic accuracy, conceptual equivalence, cultural relevance, and measurement reliability for Arabic-speaking athletes.

HYPOTHESES:

The study hypothesizes that the Arabic version of the KJOC shoulder and elbow score will demonstrate strong validity and reliability as an assessment tool for evaluating upper extremity function in symptomatic Arabic-speaking overhead athletes.

RESEARCH QUESTION:

Is the adapted Arabic version of the KJOC Shoulder and Elbow score valid and reliable for assessing upper extremity function in Egyptian symptomatic overhead athletes?

Read the detailed description

This study will use a Descriptive, Methodological Design (Cross-Cultural Adaptation).

Description of Research Methodology: The study will follow standard international guidelines for cross-cultural adaptation (e.g., Beaton et al.).

PHASE 1: CROSS-CULTURAL ADAPTATION

The process includes five stages:

  1. translation, 2) synthesis of translations, 3) back-translation to the original language, 4) committee analysis, and 5) pre-testing.

Forward Translation: Two independent translators (one medical, one naive) translate English to Arabic.

Synthesis: Merging translations into one Arabic version. Backward Translation: Translating the Arabic version back to English by two native translators.

Expert Committee Review: Reviewing all reports to reach a pre-final version. Pre-testing (Cognitive Debriefing): Testing the pre-final version on a pilot sample of athletes to ensure clarity and cultural relevance.

PHASE 2: VALIDATION AND RELIABILITY TESTING By comparing the KJOC-Arabic's concurrent validity to the Arabic DASH questionnaire and using statistical and discriminant analyses to determine its construct validity, the validity of the test will be thoroughly evaluated. Participants will complete the questionnaire twice over the course of one to two weeks in order to assess test-retest reliability. An Intraclass Correlation Coefficient (ICC) of more than 0.80 is the target. Lastly, the Cronbach's alpha-coefficient of the translated assessment tool will be determined to assess its internal consistency.

Being tested
Questionnaire and Physical Exam
Keywords
sports injury, shoulder pain, elbow pain
Medical subject headings
Elbow Injuries, Athletic Injuries, Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire and Physical ExamDiagnostic test

    This study will use a Descriptive, Methodological Design (Cross-Cultural Adaptation).

    Description of Research Methodology: The study will follow standard international guidelines for cross-cultural adaptation (e.g., Beaton et al.).

    PHASE 1: CROSS-CULTURAL ADAPTATION

    The process includes five stages:

    1. translation, 2) synthesis of translations, 3) back-translation to the original language, 4) committee analysis, and 5) pre-testing.

    Forward Translation: Two independent translators (one medical, one naive) translate English to Arabic.

    Synthesis: Merging translations into one Arabic version. Backward Translation: Translating the Arabic version back to English by two native translators.

    Expert Committee Review: Reviewing all reports to reach a pre-final version. Pre-testing (Cognitive Debriefing): Testing the pre-final version on a pilot sample of athletes to ensure clarity and cultural relevance.

    PHASE 2: VALIDATION AND RELIABILITY TESTING By comparing the KJOC-Arabic's concurrent valid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The KJOC Shoulder and Elbow score

    The KJOC Shoulder and Elbow score is used to evaluate the functional status of athletes with shoulder and elbow disorders (Appendix II) (Silva et al., 2024). The KJOC is a 10-item visual analogue scale questionnaire given to patients; lower scores indicate a lower function or performance level, while higher scores indicate a greater function or performance level. The total score, which ranges from 0 to 100 points, is determined by adding together each individual item (Alberta et al., 2010). The KJOC score is the most sensitive for distinguishing minor differences in a throwing athlete's performance (Domb et al., 2010). KJOC is valid (Spearman: KJOC and DASH sports module =- 0.8036, KJOC and DASH =-0.6933) and reliable (Cronbach alpha of 0.9, indicating a high level of inter-item reliability (Domb et al., 2010), ICC= 0.802 (Erickson et al., 2018)).

    Measured: 4 weeks

  2. Arabic version of DASH

    The DASH is a 30-item self-report survey with 5-point Likert scales. The range of scores is 0 (no disability) to 100 (the most severe disability). It is a general non-specific PROM helpful for individuals with any upper limb musculoskeletal condition (Hudak et al., 1996). Items include 21 questions evaluating particular physical tasks (e.g., using a knife or turning a key), 5 items evaluating symptoms (e.g., pain, tingling), and 4 questions evaluating social functions (e.g., sleep and confidence) (David et al., 2022). DASH has been transculturally adapted to Arabic language (Alotaibi, 2010). The DASH-Arabic is a valid, responsive, and dependable upper extremity outcome measure (Alotaibi et al., 2016), (Appendix IV).

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2026
  2. Study start1 Jun 2026
  3. Primary completion1 Jul 2026
  4. Study completion1 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
100 participants (actual)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT07729306
Sponsor's protocol ID
P.T.REC/012/006562
Acronym
Ar-KJOC
Status last verified
Jul 2026
First submitted
22 Jul 2026
Last updated
27 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Shoulder and Elbow Injury, run by Ziad Mohamed Mohamed Abdalla Haroun at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The KJOC Shoulder and Elbow score (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in